ANLN and cancer: In addition, after calculating the quantity of neoantigens of every cancer type, we demonstrated that ANLN expression was positively associated with the quantity of neoantigens in LUAD (R = 0.144, P < 0.01), BRCA (R = 0.309, P < 0.01), STAD (R = 0.405, P < 0.01), UCEC (R = 0.155, P = 0.0152), and HNSC (R = 0.137, P = 0.0225) (Figure 6(b)).